They promote the release of GLP-1 to levels about 10x higher than what the body normally produces
But as more research came out about the non-weight-loss benefits of GLP-1s and the reduced risk for multiple chronic diseases (due to the inflammatory pathways that the medication addresses), Dr
In the meantime, patients can explore existing weight loss medications like semaglutide (Ozempic and Wegovy) and tirzepatide (Zepbound and Mounjaro)
No data points were excluded
The Dietary Supplement Health and Education Act (DSHEA) of 1994 places the burden of proof on the FDA to show a supplement is unsafe, rather than requiring the manufacturer to prove it is effective
Fytili, C., Nikou, T., Tentolouris, N., Tseti, I.K., Dimosthenopoulos, C., Sfikakis, P.P., Simos, D., Kokkinos, A., Skaltsounis, A.L